News

July 15, 2026

Our CEO Bernhard Günther presented our vision for automating intravitreal injections at OIS Retina, held alongside the ASRS Annual Meeting in Montréal.

June 8, 2026

In May 2026, our robotic intravitreal injection platform completed a series of tests on ex vivo human cadaveric eyes, with every injection performed with precise, reproducible accuracy — a milestone validating the safety of the procedure.

June 1, 2026

Prof. Stephan Michels presented our poster on autonomous robotic intravitreal injection at Club Jules Gonin 2026, one of the most selective gatherings in surgical retina worldwide.

September 20, 2023

Ophthorobotics AG has won the innovator award at The European Society of Cataract and Refractive Surgeons (ESCRS)

July 10, 2023

Ophthorobotics, a preclinical-stage medtech company developing a first in class automated intravitreal injection system , announced today that it was granted a key patent for its unique drug delivery system by the european patent office (EPO).

February 28, 2023

Ophthorobotics Appoints Bernhard Günther as Chairman of the Board of Directors

June 1, 2021

Ophthorobotics will be present at the 33 German International Ophthalmologic Surgeons (DOC) Congress, which is taking place from June 17th to 19th 2021

June 1, 2021

Ophthorobotics announced today the appointment of Miguel Serrano as CEO

October 1, 2018

Ophthorobotics Appoints Roland Dreyfus as new CTO

May 1, 2018

Amanda Kayne interviews Franziska Ullrich

February 1, 2018

Opthoropotics at the "Emerging Technologies in Medicine - AI and robotics" conference 2018